Clinical Report: The Use of Albumin and Plasma Exchange for Managing TTP

Overview

This study evaluates the clinical characteristics of thrombotic thrombocytopenic purpura (TTP) with neurological symptoms and the efficacy of albumin combined with plasma exchange when plasma inventory is low.

Background

Thrombotic thrombocytopenic purpura (TTP) is a rare but serious thrombotic microangiopathy that can lead to high mortality if not treated promptly. The condition often presents with neurological symptoms, which can be mistaken for other disorders such as cerebral infarction.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• TTP can be misdiagnosed as cerebral infarction, particularly when neurological symptoms are present.
• Thrombocytopenia of unknown origin is a critical indicator for differential diagnosis of TTP.
• Albumin combined with plasma exchange is a feasible treatment option when plasma inventory is insufficient.
• Multidisciplinary collaboration is important in managing TTP cases effectively.

Clinical Implications

Clinicians should consider TTP in patients with unexplained thrombocytopenia and neurological symptoms before administering platelet transfusions.

Conclusion

Thrombotic thrombocytopenic purpura with initial neurological symptoms is easily confused with cerebral infarction, and thrombocytopenia of unknown origin is a key clue for differential screening.

Related Resources & Content

1. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura - PMC, 2020 -- Treatment guidelines for TTP
2. Intensive Care Medicine — Facilitating Transplantation for Patients with Acute-on-Chronic Liver Failure: The Role of Plasma Exchange in Managing Multiorgan Dysfunction
3. Critical Care (Springer) — Severe autoimmune hemolytic anemia in ICU: a place for emergency plasma exchange? A French multicenter retrospective study
4. Frontiers in Immunology — First application of whole blood exchange–lymphoplasmapheresis combined transfusion for restoring immune homeostasis of ceftriaxone-induced hemolytic crisis: a case report
5. Intensive Care Medicine — Exploring the Role of Extracorporeal Blood Purification in Restoring Homeostasis During Sepsis: A Critical Analysis of Recent Findings
6. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura - PMC
7. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura | New England Journal of Medicine
8. Therapeutic apheresis | Professional Education